Company intelligence / Profile preview

Synthetix

Ownership: Private
Development stage: Other

Overview

Synthetix is a healthcare data technology company focused on generating synthetic healthcare datasets for analytics, AI development, and compliant data sharing. Its platform emphasizes HIPAA-aligned synthetic data generation using epsilon-differential privacy, auditability, and interoperability features such as FHIR R4 support. The company appears to sell software and data-generation services to healthcare organizations rather than develop therapeutics. Based on the available evidence, Synthetix is a commercial-stage health data platform company, not a biotech drug developer, pharma company, or clinical-stage therapeutics company.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Synthetix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synthetix.

Explore the full profile